Naxitamab (Anti-GD2)

Ask supplier a question | View on supplier's website

Naxitamab (Anti-GD2) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2486
Sku #	A2486-1mg*5
Pricing	1mg*5, $790.00

Feedback